ArticleJTO clinical and research reports2025

Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC.

Christian Rolfo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.